Evexia Lifecare promoter group entity Shree Saibaba Exim Private Limited purchased 1,38,17,760 equity shares in the open market between September 7 and September 8, 2026. The acquisition increased the entity’s stake from 3.428% to 4.164%.

The company disclosed the transaction on September 10, 2026, under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Shree Saibaba Exim also filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

Shree Saibaba Exim acquired the shares through open market purchases on the BSE. The total value of the transaction was ₹1,38,17,760, excluding taxes and brokerage charges. No derivatives were traded in connection with this acquisition.

Holding Structure

Prior to the acquisition, Shree Saibaba Exim held 6,44,61,748 shares, representing 3.428% of the total voting capital. Post-acquisition, the holding stands at 7,82,79,508 shares, or 4.164%. None of the shares held by the entity are encumbered.

What the Numbers Show

The acquisition adds 0.736 percentage points to the promoter group’s stake in a single open-market block trade. With no encumbrances reported on the newly acquired or existing shares, the move reflects a direct increase in unpledged promoter group ownership.

The total equity share capital of Evexia Lifecare remains at 187,73,28,995 shares with a face value of ₹1 each. The diluted share capital is identical to the voting capital, indicating no outstanding convertible securities or warrants affecting the stake calculation.

Evexia Lifecare Limited approved the conversion of 50 foreign currency convertible bonds (FCCBs) into equity shares during its board meeting on September 11, 2026. The decision aligns with the terms set in the original issue approved by shareholders in July 2022.

The Board of Directors held the meeting at its corporate office in Vadodara, Gujarat. The session commenced at 10:00 am and concluded at 11:00 am on Friday.

Key Details

• The conversion involves 50 bonds being converted into equity shares.
• This action follows shareholder approval for the FCCB issue granted at the Annual General Meeting on July 9, 2022.
• The company disclosed the outcome pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

What the Numbers Show

The conversion of a specific tranche of debt instruments indicates ongoing execution of the capital structure plan approved four years ago. With only 50 bonds converted, the remaining outstanding FCCBs and their eventual conversion schedule will determine future equity dilution and liability reduction for the firm.